Back to search

3-Year Study of Donepezil Therapy in Alzheimer’s Disease: Effects of Early and Continuous Therapy

Data up to Jan 2025

Published2006
Citations171
References39

Total Citations Per Year

Abstract

References (39)

“Mini-mental state”

1975 • 82,784 citations

Clinical diagnosis of Alzheimer's disease

1984 • 27,279 citations

SAS System for Mixed Models

1996 • 10,609 citations

The Neuropsychiatric Inventory

1994 • 7,026 citations

The Global Deterioration Scale for assessment of primary degenerative dementia

1982 • 4,700 citations

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

1998 • 1,575 citations

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial

2004 • 888 citations

Galantamine in AD

2000 • 864 citations

Donepezil Improves Cognition and Global Function in Alzheimer Disease<subtitle>A 15-Week, Double-blind, Placebo-Controlled Study</subtitle>

1998 • 753 citations

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD

2001 • 723 citations

The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial<sup>1</sup>

1999 • 581 citations

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

2001 • 505 citations

Psychiatric Phenomena in Alzheimer's Disease. IV: Disorders of Behaviour

1990 • 382 citations

Open-Label, Multicenter, Phase 3 Extension Study of the Safety and Efficacy of Donepezil in Patients With Alzheimer Disease

2001 • 359 citations

The Course of Psychopathologic Features in Mild to Moderate Alzheimer Disease

1997 • 344 citations

A 52-Week Study of the Efficacy of Rivastigmine in Patients with Mild to Moderately Severe Alzheimer’s Disease

2000 • 324 citations

Predictors of cognitive and functional progression in patients with probable Alzheimer's disease

1992 • 317 citations

Donepezil Is Associated with Delayed Nursing Home Placement in Patients with Alzheimer's Disease

2003 • 314 citations

Longitudinal evaluation of dementia of the Alzheimer type

1990 • 273 citations

Long-term efficacy and safety of donepezil in the treatment of Alzheimer’s disease: final analysis of a US multicentre open-label study

2000 • 265 citations

A new rating scale for dementia syndromes

1982 • 262 citations

Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease

1996 • 248 citations

Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: Cumulative risks and APC gene mutations

2001 • 246 citations

Efficacy of Donepezil on Behavioral Symptoms in Patients With Moderate to Severe Alzheimer's Disease

2002 • 228 citations

Measurement of quality-of-life changes in patients with Alzheimer's disease.

1989 • 186 citations

The Cognitive Benefits of Galantamine Are Sustained for at Least 36 Months

2004 • 163 citations

A randomized, placebo‐controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil

2004 • 151 citations

Modelling Mini Mental State Examination changes in Alzheimer's disease

2000 • 145 citations

Cognition, Function, and Caregiving Time Patterns in Patients With Mild-to-Moderate Alzheimer Disease

2005 • 97 citations

The Gottfries-Bråne-Steen Scale: Validity, Reliability and Application in Anti-Dementia Drug Trials

2000 • 75 citations

Personality Alterations in Dementia of the Alzheimer Type: A Three-Year Follow-up Study

1989 • 68 citations

Some Statistical Issues in the Analyses of Data From Longitudinal Studies of Elderly Chronic Care Populations

2002 • 53 citations

Potential treatment effects of donepezil not detected in Alzheimer's disease clinical trials: a physician survey

2004 • 48 citations

Cognitive Decline in Alzheimer's Disease: Elaborating on the Nature of the Longitudinal Factor Structure of the Mini-Mental State Examination

1993 • 35 citations

Analysis of longitudinal data in an Alzheimer's disease clinical trial

2000 • 20 citations

METHODOLOGICAL CONCERNS: LONGITUDINAL STUDIES OF DEMENTIA

1987 • 15 citations

Mixed-model analysis of incomplete longitudinal data from a high-dose trial of tacrine (cognex®) in alzheimer's patients

1996 • 15 citations

Gutartige Tumore der Papilla Vateri

2000 • 12 citations

Overview of methodological issues in the study of chronic care populations.

1994 • 6 citations

Cited By (0)

Loading...